G-quadruplex in cancer energy metabolism: A potential therapeutic target

Zongqiang Han1, Lina Wen2

  • 1Department of Laboratory Medicine, Beijing Xiaotangshan Hospital, Beijing 102211, China.

Insights

G-quadruplexes (G4) regulate cancer cell functions and are implicated in energy metabolism. This review highlights G4

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer energy metabolism is crucial for tumor biology.
  • Transcription factors, mitochondria, reactive oxygen species (ROS), and autophagy-lysosome systems are key regulators.
  • G-quadruplexes (G4) are emerging as regulators of gene expression and potential anticancer targets.

Purpose of the Study:

  • To systematically elucidate the role of G4 in cancer energy metabolism.
  • To analyze the correlation between G4 and key regulatory elements of cancer metabolism.
  • To explore G4 as a potential target for anticancer strategies.

Main Methods:

  • Literature review and analysis of existing research.
  • Examination of the interplay between G4 structures and cancer-related pathways.
  • Summarization of studies on G4 ligands and their effects on cancer metabolism.

Main Results:

  • G4 structures are closely correlated with transcription factors, mitochondria, ROS, and autophagy-lysosome systems.
  • G4 influences cancer energy metabolism by regulating these key elements.
  • G4 ligands demonstrate anticancer effects via modulation of energy metabolism.

Conclusions:

  • G4 plays a significant role in regulating cancer energy metabolism.
  • G4 represents a promising target for novel anticancer strategies focused on metabolic pathways.
  • Further research is warranted to fully understand G4's role in cancer metabolism.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K